Your browser doesn't support javascript.
loading
Pretreatment evaluation of fluorescence resonance energy transfer-based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib.
Kondo, Takeshi; Fujioka, Mari; Tsuda, Masumi; Murai, Kazunori; Yamaguchi, Kohei; Miyagishima, Takuto; Shindo, Motohiro; Nagashima, Takahiro; Wakasa, Kentaro; Fujimoto, Nozomu; Yamamoto, Satoshi; Yonezumi, Masakatsu; Saito, Souichi; Sato, Shinji; Ogawa, Kazuei; Chou, Takaaki; Watanabe, Reiko; Kato, Yuichi; Takahashi, Shuichiro; Okano, Yoshiaki; Yamamoto, Joji; Ohta, Masatsugu; Iijima, Hiroaki; Oba, Koji; Kishino, Satoshi; Sakamoto, Junichi; Ishida, Yoji; Ohba, Yusuke; Teshima, Takanori.
Affiliation
  • Kondo T; Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Fujioka M; Department of Cell Physiology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Tsuda M; Department of Cancer Pathology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Murai K; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Yamaguchi K; Division of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Miyagishima T; Department of Internal Medicine, Japan Labour Health and Welfare Organization, Kushiro Rosai Hospital, Kushiro, Japan.
  • Shindo M; Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan.
  • Nagashima T; Department of Internal Medicine/General Medicine, Kitami Red Cross Hospital, Kitami, Japan.
  • Wakasa K; Division of Hematology, Hokkaido P.W.F.A.C. Obihiro-Kosei General Hospital, Obihiro, Japan.
  • Fujimoto N; Division of Hematology, Kaisei Hospital, Sapporo, Japan.
  • Yamamoto S; Department of Hematology, Sapporo City General Hospital, Sapporo, Japan.
  • Yonezumi M; Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan.
  • Saito S; Department of Internal Medicine, Nihonkai General Hospital, Sakata, Japan.
  • Sato S; Department of Hematology, Okitama Public General Hospital, Okitama, Japan.
  • Ogawa K; Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan.
  • Chou T; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
  • Watanabe R; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
  • Kato Y; Department of Hematology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Takahashi S; Department of Hematology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Okano Y; Department of Hematology, Iwate Prefectural Miyako Hospital, Miyako, Japan.
  • Yamamoto J; Department of Hematology, Sendai City Hospital, Sendai, Japan.
  • Ohta M; Department of Hematology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Japan.
  • Iijima H; Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan.
  • Oba K; Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kishino S; Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Kiyose, Japan.
  • Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
  • Ishida Y; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Ohba Y; Department of Cell Physiology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Teshima T; Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Cancer Sci ; 109(7): 2256-2265, 2018 Jul.
Article in En | MEDLINE | ID: mdl-29719934
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosensing Techniques / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Patient Selection / Fluorescence Resonance Energy Transfer Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2018 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosensing Techniques / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Patient Selection / Fluorescence Resonance Energy Transfer Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2018 Type: Article Affiliation country: Japan